MIT Tech Review: How AI is Transforming Drug Development

/** * Implements hook_preprocess_HOOK() for paragraph__egnyte_product_tour_feed. */ function egnyte_product_tour_feed_preprocess_paragraph__egnyte_product_tour_feed(array &$variables) { // Load Bundle. $variables['#attached']['library'][] = 'egnyte_site_builder/product-tour-feed-block-js'; $pt_filter = []; $paragraph = $variables['elements']['#paragraph']; $product_tours = EgnyteProductTourFeed::getInstance(); $selected_pt = $paragraph->field_egnyte_product_tour_list->getValue() ?? []; // Array of Custom "All Product Tours" Filter nodes. foreach ($selected_pt as $key => $value) { $pt_filter['target_id'][$key] = $value['target_id']; } $variables['product_button_header'] = 'All Product Tours'; $variables['product_tours'] = !empty($selected_pt) ? EgnyteProductTourFeed::getInstance()->getProductToursByNids($pt_filter['target_id']) : $pr MIT Tech Review: How AI is Transforming Drug Development | Egnyte

Products

EGNYTE PRODUCTS

Product Overview Collaboration Intelligence Governance Integrations Platform Product Tours

MIT Tech Review: How AI is Transforming Drug Development

A Closer Look at MIT Tech Review's Predictions For AI-Led Drug Development. In this roundtable, Holly Leslie will interview our two guests, will discuss the latest findings from MIT Tech Review and offer perspectives on how AI is reshaping the way drugs are brought to market.

Behrooz Najafi

Chief Technology Officer / Chief Information Officer

Holly Leslie

Sr. Director, Life Sciences

Egnyte

Nagaraja Srivatsan

Chief Digital Officer, R&D Technology Solutions

IQVIA

Jason Sparapani

Content Manager, Insights

MIT Tech Review